Form 8-K - Current report:
SEC Accession No. 0000950170-25-112570
Filing Date
2025-09-03
Accepted
2025-09-02 17:34:38
Documents
13
Period of Report
2025-08-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cytk-20250831.htm   iXBRL 8-K 41849
2 EX-99.1 cytk-ex99_1.htm EX-99.1 81507
3 GRAPHIC img114956760_0.jpg GRAPHIC 23462
4 GRAPHIC img114956760_1.jpg GRAPHIC 120062
  Complete submission text file 0000950170-25-112570.txt   426478

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cytk-20250831.xsd EX-101.SCH 25033
15 EXTRACTED XBRL INSTANCE DOCUMENT cytk-20250831_htm.xml XML 4753
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

EIN.: 943291317 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50633 | Film No.: 251286757
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)